Literature DB >> 23395156

Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms.

Xiaofeng Chen1, Hong Lu, Debra L Rateri, Lisa A Cassis, Alan Daugherty.   

Abstract

Angiotensin II (AngII) has been invoked as a principal mediator for the development and progression of both thoracic and abdominal aortic aneurysms. While there is consistency in experimental and clinical studies that overactivation of the renin angiotensin system promotes aortic aneurysm development, there are many unknowns regarding the mechanistic basis underlying AngII-induced aneurysms. Interactions of AngII with TGF-β in both thoracic and abdominal aortic aneurysms have been the focus of recent studies. While these studies have demonstrated profound effects of manipulating TGF-β activity on AngII-induced aortic aneurysms, they have also led to more questions regarding the interactions between AngII and this multifunctional cytokine. This review compiled the recent literature to provide insights into understanding the potentially complex interactions between AngII and TGF-β in the development of aortic aneurysms.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23395156      PMCID: PMC3691307          DOI: 10.1016/j.coph.2013.01.002

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  35 in total

Review 1.  Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

Authors:  Puja K Mehta; Kathy K Griendling
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-26       Impact factor: 4.249

2.  Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Authors:  Jennifer P Habashi; Daniel P Judge; Tammy M Holm; Ronald D Cohn; Bart L Loeys; Timothy K Cooper; Loretha Myers; Erin C Klein; Guosheng Liu; Carla Calvi; Megan Podowski; Enid R Neptune; Marc K Halushka; Djahida Bedja; Kathleen Gabrielson; Daniel B Rifkin; Luca Carta; Francesco Ramirez; David L Huso; Harry C Dietz
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

Review 3.  Transforming growth factor-betas and vascular disorders.

Authors:  Alex Bobik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05-04       Impact factor: 8.311

4.  Transforming growth factor-beta(1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts.

Authors:  V V Petrov; R H Fagard; P J Lijnen
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2000-12       Impact factor: 1.636

5.  Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells. Direct stimulation and indirect inhibition via transforming growth factor-beta 1.

Authors:  G Liu; E Espinosa; B S Oemar; T F Lüscher
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-07       Impact factor: 8.311

6.  Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.

Authors:  Benjamin S Brooke; Jennifer P Habashi; Daniel P Judge; Nishant Patel; Bart Loeys; Harry C Dietz
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

Review 7.  TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility.

Authors:  Bernhard Schmierer; Caroline S Hill
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

8.  Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture.

Authors:  Victoria L King; Alexander Y Lin; Fjoralba Kristo; Thomas J T Anderson; Neil Ahluwalia; Gregory J Hardy; A Phillip Owens; Deborah A Howatt; Dongxiao Shen; Andrew M Tager; Andrew D Luster; Alan Daugherty; Robert E Gerszten
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

9.  Essential role of Smad3 in angiotensin II-induced vascular fibrosis.

Authors:  Wansheng Wang; Xiao R Huang; Ellery Canlas; Kazuhiro Oka; Luan D Truong; Chuxia Deng; Neil A Bhowmick; Wenjun Ju; Erwin P Bottinger; Hui Y Lan
Journal:  Circ Res       Date:  2006-03-23       Impact factor: 17.367

10.  TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice.

Authors:  Yu Wang; Hafid Ait-Oufella; Olivier Herbin; Philippe Bonnin; Bhama Ramkhelawon; Soraya Taleb; Jin Huang; Georges Offenstadt; Christophe Combadière; Laurent Rénia; Jason L Johnson; Pierre-Louis Tharaux; Alain Tedgui; Ziad Mallat
Journal:  J Clin Invest       Date:  2010-01-25       Impact factor: 14.808

View more
  24 in total

Review 1.  TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.

Authors:  Elena Gallo MacFarlane; Julia Haupt; Harry C Dietz; Eileen M Shore
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

2.  Lineage-specific events underlie aortic root aneurysm pathogenesis in Loeys-Dietz syndrome.

Authors:  Elena Gallo MacFarlane; Sarah J Parker; Joseph Y Shin; Benjamin E Kang; Shira G Ziegler; Tyler J Creamer; Rustam Bagirzadeh; Djahida Bedja; Yichun Chen; Juan F Calderon; Katherine Weissler; Pamela A Frischmeyer-Guerrerio; Mark E Lindsay; Jennifer P Habashi; Harry C Dietz
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

3.  Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome.

Authors:  Jorge Oller; Nerea Méndez-Barbero; E Josue Ruiz; Silvia Villahoz; Marjolijn Renard; Lizet I Canelas; Ana M Briones; Rut Alberca; Noelia Lozano-Vidal; María A Hurlé; Dianna Milewicz; Arturo Evangelista; Mercedes Salaices; J Francisco Nistal; Luis Jesús Jiménez-Borreguero; Julie De Backer; Miguel R Campanero; Juan Miguel Redondo
Journal:  Nat Med       Date:  2017-01-09       Impact factor: 53.440

4.  Aortic aneurysms in Loeys-Dietz syndrome - a tale of two pathways?

Authors:  Frank Davis; Debra L Rateri; Alan Daugherty
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

Review 5.  Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections.

Authors:  Jay D Humphrey; Martin A Schwartz; George Tellides; Dianna M Milewicz
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

6.  Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.

Authors:  Nancy R Webb; Maria C De Beer; Joanne M Wroblewski; Ailing Ji; William Bailey; Preetha Shridas; Richard J Charnigo; Victoria P Noffsinger; Jassir Witta; Deborah A Howatt; Anju Balakrishnan; Debra L Rateri; Alan Daugherty; Frederick C De Beer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

Review 7.  Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall.

Authors:  Gianluca L Perrucci; Erica Rurali; Aoife Gowran; Alessandro Pini; Carlo Antona; Roberto Chiesa; Giulio Pompilio; Patrizia Nigro
Journal:  Cell Mol Life Sci       Date:  2016-08-17       Impact factor: 9.261

8.  TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.

Authors:  Stoyan N Angelov; Jie Hong Hu; Hao Wei; Nathan Airhart; Minghui Shi; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07-20       Impact factor: 8.311

9.  Cell Type-Specific Contributions of the Angiotensin II Type 1a Receptor to Aorta Homeostasis and Aneurysmal Disease-Brief Report.

Authors:  Josephine Galatioto; Cristina I Caescu; Jens Hansen; Jason R Cook; Irving Miramontes; Ravi Iyengar; Francesco Ramirez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-25       Impact factor: 8.311

10.  Matricellular protein CCN3 mitigates abdominal aortic aneurysm.

Authors:  Chao Zhang; Dustin van der Voort; Hong Shi; Rongli Zhang; Yulan Qing; Shuichi Hiraoka; Minoru Takemoto; Koutaro Yokote; Joseph V Moxon; Paul Norman; Laure Rittié; Helena Kuivaniemi; G Brandon Atkins; Stanton L Gerson; Guo-Ping Shi; Jonathan Golledge; Nianguo Dong; Bernard Perbal; Domenick A Prosdocimo; Zhiyong Lin
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.